Neurocrine Biosciences, Inc. · NASDAQ:NBIX
Neurocrine Biosciences, Inc. shareholders
As of Jun 30, 2026, 759 institutions reported holding Neurocrine Biosciences, Inc., 99.5% of its shares. Largest: BlackRock, Vanguard and JPMorgan. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Neurocrine Biosciences, Inc. | Change | Filed |
|---|---|---|---|---|
| BlackRock | 13.7M | 13.5% | +326K | Aug 7, 2026 |
| Vanguard | 10.3M | 10.1% | +296K | Aug 13, 2026 |
| JPMorgan | 6.4M | 6.3% | +957K | Aug 12, 2026 |
| Dodge & Cox | 5.58M | 5.5% | +124K | Aug 13, 2026 |
| State Street | 4.39M | 4.3% | +31,072 | Aug 7, 2026 |
| AQR Capital Management LLC | 3.82M | 3.8% | −1.12M | Aug 14, 2026 |
| Renaissance Technologies | 2.34M | 2.3% | −83,000 | Aug 13, 2026 |
| Geode Capital | 2.14M | 2.1% | +2,105 | Aug 12, 2026 |
| Two Sigma | 2.08M | 2.0% | −984K | Aug 14, 2026 |
| Vestal Point Capital, LP | 1.88M | 1.8% | +630K | Aug 14, 2026 |